Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Bioequivalence Experimental Study Designs: Repeated Measures, Cross-Over, Carry-Over, and Latin Square Designs01:15

Bioequivalence Experimental Study Designs: Repeated Measures, Cross-Over, Carry-Over, and Latin Square Designs

367
Bioequivalence experimental study designs play a pivotal role in testing the effectiveness of various treatments. Key among these are the repeated measures, cross-over, carry-over, and Latin square designs. In the repeated measures design, each subject receives all treatments, allowing for temporal comparisons. This type of design is useful in reducing variability but requires careful planning to avoid bias.The cross-over design, an economical method, involves sequential administration of...
367
Crossover Experiments01:16

Crossover Experiments

4.7K
Crossover experiments, also called the repeated-measurements design, is a study design in which all experimental units are exposed to all treatments in different periods. Crossover experiments are generally used in psychology, the pharmaceutical industry, agriculture, and medicine.
Crossover designs are performed even with smaller sample sizes since the samples can act as their controls. These are better than simple randomized trials since patients are exposed to all the treatments.
4.7K
Bioequivalence Experimental Study Designs: Completely Randomized and Randomized Block Designs01:20

Bioequivalence Experimental Study Designs: Completely Randomized and Randomized Block Designs

355
Bioequivalence experimental study designs are crucial methodologies used in evaluating and comparing the bioavailability of different drug products. These designs are categorized into various types: completely randomized, randomized block, repeated measures, cross and carry-over, and Latin square designs.Completely randomized designs involve randomly allocating treatments to all subjects participating in the experiment. This allocation is achieved by assigning unique random numbers to subjects...
355
Comparing the Survival Analysis of Two or More Groups01:20

Comparing the Survival Analysis of Two or More Groups

692
Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and...
692
Bioequivalence Data: Statistical Interpretation01:16

Bioequivalence Data: Statistical Interpretation

308
The statistical interpretation of bioequivalence data is a significant aspect of pharmaceutical research. Bioequivalence refers to the absence of any significant difference in the rate and extent to which the active ingredient in pharmaceutical products becomes available at the site of drug action when administered at the same molar dose under similar conditions. This helps determine if different drug products have similar absorption rates, ensuring their interchangeability.Statistical...
308
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches01:23

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches

520
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
520

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Functional and Metabolic Adaptations of Blood Flow Restriction Exercise in Rats and Post-surgical Patients.

medRxiv : the preprint server for health sciences·2026
Same author

Quantifying the Tolerability of Dopamine Agonist Antiparkinsonian Medication Side Effects: A Best-Worst Scaling Survey.

Patient preference and adherence·2026
Same author

A Qualitative Study on Perspectives of Parkinson's Disease Medications: Insights from Patient Focus Groups.

Patient preference and adherence·2024
Same author

A Retrospective Cohort Study to Determine Real-World Treatment Patterns in Patients with Sézary Syndrome in the United States.

Oncology and therapy·2024
Same author

Real-world treatment patterns of patients with major depressive disorder treated with Auvelity in the United States.

Journal of medical economics·2024
Same author

Real-world antiseizure medication treatment outcomes in drug-resistant focal epilepsy patients.

Epilepsia open·2023

Related Experiment Video

Updated: Mar 18, 2026

Inverse Probability of Treatment Weighting Propensity Score using the Military Health System Data Repository and National Death Index
06:55

Inverse Probability of Treatment Weighting Propensity Score using the Military Health System Data Repository and National Death Index

Published on: January 8, 2020

15.4K

Difference-in-Differences Method in Comparative Effectiveness Research: Utility with Unbalanced Groups.

Huanxue Zhou1, Christopher Taber2, Steve Arcona3

  • 1KMK Consulting, Inc., 7 North Tower, 23 Headquarters Plaza, Morristown, NJ, 07960, USA.

Applied Health Economics and Health Policy
|July 3, 2016
PubMed
Summary
This summary is machine-generated.

Difference-in-differences (DiD) effectively estimated treatment outcomes in multiple sclerosis (MS) patients switching therapies. This method robustly compared diverse patient groups, showing reduced relapse rates after switching medication.

More Related Videos

Applying an eMASS Customization Program as a Research Tool to Evaluate Consumer Benefits
08:27

Applying an eMASS Customization Program as a Research Tool to Evaluate Consumer Benefits

Published on: September 27, 2019

7.3K
Author Spotlight: Evaluating the Adjuvant Efficacy and Safety of Angong Niuhuang Pill in Viral Encephalitis Treatment
08:36

Author Spotlight: Evaluating the Adjuvant Efficacy and Safety of Angong Niuhuang Pill in Viral Encephalitis Treatment

Published on: April 19, 2024

1.3K

Related Experiment Videos

Last Updated: Mar 18, 2026

Inverse Probability of Treatment Weighting Propensity Score using the Military Health System Data Repository and National Death Index
06:55

Inverse Probability of Treatment Weighting Propensity Score using the Military Health System Data Repository and National Death Index

Published on: January 8, 2020

15.4K
Applying an eMASS Customization Program as a Research Tool to Evaluate Consumer Benefits
08:27

Applying an eMASS Customization Program as a Research Tool to Evaluate Consumer Benefits

Published on: September 27, 2019

7.3K
Author Spotlight: Evaluating the Adjuvant Efficacy and Safety of Angong Niuhuang Pill in Viral Encephalitis Treatment
08:36

Author Spotlight: Evaluating the Adjuvant Efficacy and Safety of Angong Niuhuang Pill in Viral Encephalitis Treatment

Published on: April 19, 2024

1.3K

Area of Science:

  • Comparative effectiveness research
  • Observational studies
  • Health economics and outcomes research

Background:

  • Comparative effectiveness research (CER) frequently uses administrative data for observational studies.
  • Difference-in-differences (DiD) is a key method for adjusting group differences in CER.
  • This study applies DiD to a real-world multiple sclerosis (MS) patient population.

Purpose of the Study:

  • To present and demonstrate the application of DiD estimation.
  • To estimate treatment outcomes in MS patients using MarketScan® Databases.
  • To compare therapies in a heterogeneous patient population.

Main Methods:

  • Utilized a US administrative claims database (MarketScan®).
  • Included 6762 MS patients: 363 in the Test Cohort (glatiramer acetate to fingolimod switch) and 6399 in the Control Cohort (glatiramer acetate only).
  • Employed DiD analysis and logistic regression to compare relapse rates before and after treatment switch.

Main Results:

  • Pre-index period: Test Cohort had significantly higher MS relapse rates than the Control Cohort.
  • Post-index period: No significant between-group differences in relapse rates were observed initially.
  • Generalized linear modeling with DiD regression showed a significant decrease in mean MS relapses in the post-index period for the Test Cohort compared to the Control Cohort.

Conclusions:

  • DiD is a robust method for estimating treatment effects in heterogeneous populations.
  • The study successfully demonstrated DiD application in an MS patient cohort.
  • DiD is valuable when traditional risk-adjustment methods may be insufficient.